% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, AŞ Message Board

  • drjwater drjwater Jul 2, 2013 10:10 AM Flag

    PATH is on buyout and take over target, GSK owns 8.9% plus


    Small float, FDA approved target, patents, this new Migrain treatment has tons of other potential. Oh yea did I say that GSK now owns 8.9% and the company is in talks with partnership or buyout. PATH is a major take over target.

    Sentiment: Strong Buy

    This topic is deleted.